Supplements That May Lower ApoB Levels

Last Updated: March 2026

Disclosure: This article contains affiliate links. We may earn a commission at no extra cost to you. See our full disclosure.

Supplements That Lower ApoB: What the Evidence Actually Shows

Omega-3 fatty acids (EPA/DHA) and niacin (vitamin B3) have the strongest research support for lowering apolipoprotein B (ApoB). Plant sterols and berberine also demonstrate modest ApoB-lowering effects in clinical trials. However, no supplement approaches the potency of statin medications, which remain the gold standard for significant ApoB reduction. Supplements are best viewed as complementary tools, not replacements for pharmaceutical intervention when ApoB levels are substantially elevated.

Why ApoB Matters More Than LDL Cholesterol

ApoB has emerged as the single best blood marker for predicting cardiovascular disease risk. Dr. Peter Attia has made this a central point of his longevity framework, arguing on The Drive podcast and in his book Outlive that ApoB is superior to standard LDL cholesterol because it measures the actual number of atherogenic particles in the blood, not just the cholesterol they carry. Each particle capable of embedding in an artery wall contains exactly one ApoB molecule, making the ApoB count a direct measure of cardiovascular danger. Attia recommends most people aim for an ApoB below 60 mg/dL, and ideally below 40 mg/dL for those with additional risk factors.

For a full breakdown of what ApoB is and why it’s replacing LDL-C as the primary metric among longevity physicians, read our detailed guide: What Is ApoB and Why Does It Matter?

Supplements with Evidence for ApoB Reduction

Omega-3 Fatty Acids (EPA/DHA)

High-dose EPA and DHA (2-4 grams per day) consistently reduce ApoB by approximately 5-10% in clinical trials. The effect is driven primarily by EPA, which lowers triglyceride-rich lipoproteins that carry ApoB. The REDUCE-IT trial showed that 4g of icosapent ethyl (pure EPA) reduced cardiovascular events by 25%. For a deeper look at dosing and product quality, see our omega-3 fish oil guide.

High-dose omega-3 has the strongest evidence for ApoB reduction. See our best high-potency fish oil supplements for concentrated EPA/DHA options.

Niacin (Vitamin B3)

Niacin at therapeutic doses (1,500-2,000 mg/day) can lower ApoB by 10-15%. It is one of the few supplements that also raises HDL and lowers lipoprotein(a). However, niacin causes flushing in most users and carries liver toxicity risk at high doses. It should only be used under physician supervision.

Plant Sterols and Stanols

Consuming 2-3 grams of plant sterols daily reduces LDL cholesterol by roughly 6-12% and produces a corresponding ApoB reduction. They work by competing with cholesterol for absorption in the gut. Available in fortified foods and standalone supplements.

Berberine

Berberine at 500 mg two to three times daily has shown LDL and ApoB reductions of 5-15% in several clinical trials. It works through a mechanism partially overlapping with statins (upregulating LDL receptors). Dr. Brad Stanfield has reviewed berberine’s cardiovascular evidence on his YouTube channel, noting it is one of the more promising natural compounds for lipid management.

What Longevity Experts Recommend for ApoB Management

Here’s where the rubber meets the road: what do the people who obsess over this stuff actually do?

Dr. Peter Attia has been transparent about his approach. For patients with elevated ApoB, he reaches for pharmacological tools first — statins, ezetimibe, PCSK9 inhibitors — because the magnitude of reduction matters. But he doesn’t dismiss supplements. On The Drive, he has noted that high-dose EPA (not just generic fish oil — concentrated EPA specifically) is one of the few supplements with hard cardiovascular endpoint data behind it, thanks to the REDUCE-IT trial. His recommendation for patients who are already on medication: add 2-4g of EPA/DHA daily as an adjunct, not an alternative.

Dr. Brad Stanfield takes a more supplement-forward approach in his YouTube breakdowns. He has specifically reviewed berberine as a statin alternative for people who refuse or cannot tolerate medication, noting the meta-analysis data showing 5-15% ApoB reductions. His caveat is important though: berberine’s effect size is a fraction of what statins deliver, so it’s only appropriate when ApoB is mildly elevated and overall cardiovascular risk is low.

Rhonda Patrick has emphasized the omega-3 angle on FoundMyFitness, pointing to research showing that EPA specifically reduces ApoB-containing VLDL particles. She has discussed the importance of the omega-3 index (target: 8-12%) as a proxy for whether you’re getting enough EPA/DHA to meaningfully impact lipid profiles. Her recommendation: test your omega-3 index alongside ApoB to see if your current intake is actually moving the needle.

For a broader look at how these experts structure their entire supplement protocols — including their cardiovascular stacks — see our expert stacks compared hub.

Building an ApoB-Lowering Supplement Stack

If you’re going the supplement route — either because your ApoB is only mildly elevated, you’re already on medication and want additional support, or you’re building up to a conversation with your doctor about your numbers — here’s what a reasonable evidence-based stack looks like:

Combining omega-3s, berberine, and plant sterols — without niacin — is the most practical stack for most people. That combination might deliver a total ApoB reduction of 10-20%, which is meaningful but still modest compared to pharmaceutical options. If you’re building a broader cardiovascular supplement stack, check our best heart health supplements for options that go beyond just ApoB.

The honest take: if your ApoB is above 100 mg/dL, supplements alone are almost certainly not going to get you to the sub-60 target that Attia and most longevity physicians recommend. Have the medication conversation with your doctor. Supplements can optimize, but they can’t replace serious pharmacological intervention when the numbers demand it.

Realistic Expectations

A well-chosen supplement stack might lower ApoB by 10-20% in total when combining multiple approaches. For someone with an ApoB of 120 mg/dL, that could mean a reduction to 96-108 mg/dL, which is still above the optimal targets most longevity physicians recommend. By comparison, a moderate-dose statin typically reduces ApoB by 30-50%. This is why Attia and most cardiologists recommend medication as the first-line intervention for elevated ApoB, with supplements playing a supporting role.

Track your ApoB levels over time to measure supplement impact. See our best at-home blood test services for panels that include lipid markers.

To understand what other markers to track alongside ApoB, see our longevity blood tests guide. For evidence-based heart health supplements, see our best supplements for heart health roundup. And if you’re wondering whether to get bloodwork done before starting any of these supplements, the answer is yes — our guide on blood work before supplements explains why baseline numbers matter.

Frequently Asked Questions

Can supplements replace statins for lowering ApoB?

For most people with significantly elevated ApoB, no. Supplements typically produce 5-15% reductions individually, while statins achieve 30-50%. If your ApoB is only mildly elevated and you are otherwise low-risk, a supplement-first approach may be reasonable to discuss with your physician. For moderate to high-risk individuals, statins remain far more effective.

How long does it take for supplements to lower ApoB?

Most lipid-lowering supplements reach their full effect within 8-12 weeks of consistent daily use. Retest your ApoB at the 3-month mark to evaluate whether the supplement strategy is producing meaningful change.

What ApoB level should I target?

Dr. Peter Attia recommends an ApoB below 60 mg/dL for most adults pursuing optimal cardiovascular health, and below 40 mg/dL for those with family history of heart disease or additional risk factors. The American College of Cardiology considers anything below 90 mg/dL desirable for standard-risk patients.

This content reports on published research and expert commentary. It is not medical advice. Consult a qualified healthcare provider before making changes to your cardiovascular health regimen.